| 000 | 01091 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514072304.0 | ||
| 264 | 0 | _c20030721 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a1367-6733 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSikorski, J A | |
| 245 | 0 | 0 |
_aThe discovery of new cholesteryl ester transfer protein inhibitors. _h[electronic resource] |
| 260 |
_bCurrent opinion in drug discovery & development _cSep 2001 |
||
| 300 |
_a602-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCholesterol Ester Transfer Proteins |
| 650 | 0 | 4 | _aGlycoproteins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xpharmacology |
| 650 | 0 | 4 |
_aPeptides _xpharmacology |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aConnolly, D T | |
| 773 | 0 |
_tCurrent opinion in drug discovery & development _gvol. 4 _gno. 5 _gp. 602-13 |
|
| 999 |
_c12608514 _d12608514 |
||